Sanofi Taxotere Hair-Loss Claims Not Barred by Federal Law

Sanofi U.S. Services Inc. and related companies must face a woman’s suit alleging they failed to warn that the cancer drug Taxotere could cause permanent hair loss, following a Louisiana federal court’s ruling that federal law doesn’t preempt all claims.

The drugmakers could have unilaterally changed the label before Elizabeth Kahn was treated in 2008, and didn’t offer “clear evidence” the Food and Drug Administration would have rejected an enhancement, Judge Jane Triche Milazzo of the U.S. District Court for the Eastern District of Louisiana said Dec. 18.

Because there is no conflict between Kahn’s Louisiana law product liability claims ...